Wangfu 250 Tablet contains Cefuroxime 250 mg, a second-generation cephalosporin antibiotic effective against a broad spectrum of Gram-positive and Gram-negative bacteria. It is indicated for the treatment of various bacterial infections including respiratory tract infections such as bronchitis and pneumonia, urinary tract infections, skin and soft tissue infections, and uncomplicated gonorrhea. Cefuroxime exerts its bactericidal action by inhibiting bacterial cell wall synthesis, leading to cell lysis and death. Wangfu 250 is administered orally and is well absorbed, with peak plasma concentrations typically achieved within 2 to 3 hours post-dose. It is important to complete the full prescribed course to prevent the development of resistance. Dosage adjustments may be necessary in patients with renal impairment. Common adverse effects include gastrointestinal disturbances such as diarrhea, nausea, and abdominal discomfort, as well as hypersensitivity reactions in patients allergic to beta-lactam antibiotics. Caution is advised in individuals with a history of penicillin allergy. Wangfu 250 should be used under medical supervision, and therapy should be guided by culture and sensitivity results whenever possible to ensure optimal efficacy and minimize resistance development.